<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Kenvue Separation on FinanClub</title>
    <link>https://finan.club/tags/kenvue-separation/</link>
    <description>Recent content in Kenvue Separation on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 11 Sep 2023 05:44:48 +0000</lastBuildDate><atom:link href="https://finan.club/tags/kenvue-separation/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>JNJ</title>
      <link>https://finan.club/us/jnj/</link>
      <pubDate>Mon, 11 Sep 2023 05:44:48 +0000</pubDate>
      
      <guid>https://finan.club/us/jnj/</guid>
      <description>score:65
Chances: Johnson &amp;amp; Johnson recently completed the separation of Kenvue, which could lead to better focus and growth opportunities in the pharmaceutical and medical tech sectors. The company forecasts double-digit earnings growth after the Kenvue spin-off, indicating a positive outlook. J&amp;amp;J continues to generate strong free cash flow, supporting its dividend decisions and financial stability.</description>
    </item>
    
  </channel>
</rss>
